Vaccines

11 Dec 2017 Altimmune Submits Investigational New Drug Application for NasoShield in Preparation for its Phase 1 Trial
07 Dec 2017 Aptinyx Granted Fast Track Designation, Initiates Phase 1 for Second Clinical Candidate, NYX-783, in Post-Traumatic Stress Disorder
07 Dec 2017 Vertex Announces Positive Results from Open-Label Phase 3 Study of KALYDECO(R) (ivacaftor) in Children with Cystic Fibrosis Ages 1 to 2 Years
06 Dec 2017 New data supports the safety and efficacy of GSK’s Shingrix in preventing shingles in autologous haematopoietic stem cell transplant patients
05 Dec 2017 100% of Prostate Cancer Patients Completing 31-Week Post-Therapy Exam After Treatment with OncBioMune Immunotherapy Show No Disease Progression
05 Dec 2017 ObsEva Initiates PROLONG, the Phase 2a Clinical Trial of OBE022 in Preterm Labor
05 Dec 2017 Immunovaccine Announces Positive Clinical Data from Its Collaborative Combination Immunotherapy Trial in Advanced Ovarian Cancer
04 Dec 2017 Ovid Therapeutics Presents New Data Demonstrating Potential of TAK-935/OV935 as a Novel Treatment for Developmental and Epileptic Encephalopathies at the American Epilepsy Society (AES) Annual Meeting
04 Dec 2017 Sanofi ends development of Clostridium difficile vaccine
29 Nov 2017 Sanofi updates information on dengue vaccine
28 Nov 2017 Takeda Initiates Phase 1 Clinical Trial of Zika Vaccine Candidate
28 Nov 2017 SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer
27 Nov 2017 Medigene AG: Patient recruitment completed for Phase I/II DC vaccine trial in AML
27 Nov 2017 Inovio Pharmaceuticals SynCon® TERT Cancer Immunotherapy Combined with Checkpoint Inhibitor Synergistically Shrinks Tumor and Improves Survival in Preclinical Tumor Model
15 Nov 2017 Moderna Announces First-in-Human Dosing for Phase 1 Study (KEYNOTE-603) of mRNA-4157, a Personalized Cancer Vaccine, for the Treatment of Solid Tumors
13 Nov 2017 80% of Prostate Cancer Patients in OncBioMune Phase 1 Clinical Trial of ProscaVax Show No Disease Progression at the First Post-Therapy Follow-up
13 Nov 2017 NousCom's Neoantigen-based Vaccine Synergizes With NKTR-214 to Cure Established Tumors in Preclinical Model
12 Nov 2017 Argos Therapeutics Provides Update on Immunology Data from the Phase 3 ADAPT Trial Presented at the SITC 2017 Annual Meeting
12 Nov 2017 Dynavax Announces FDA Approval of HEPLISAV-B(TM) for Prevention of Hepatitis B in Adults
10 Nov 2017 Inovio Pharmaceuticals Presents Immuno-Oncology Advancements At Society for Immunotherapy of Cancer Conference
09 Nov 2017 Bavarian Nordic Announces Initiation of Phase 2 Booster Study of its Universal RSV Vaccine
08 Nov 2017 Immunovaccine Announces Regulatory Clearance for Phase 2 Clinical Trial Evaluating DPX-Survivac in Combination with Merck’s Checkpoint Inhibitor Pembrolizumab in DLBCL
08 Nov 2017 Batu Biologics Receives FDA Clearance for First Multi-Pronged Immunotherapy Targeting the Blood Vessels that Feed Cancer
08 Nov 2017 Pique Therapeutics Announces Positive Results in Phase 2 Clinical Trial of Lead Immunotherapy for Non-Small Cell Lung Cancer
08 Nov 2017 Genocea Presents New Data Demonstrating the Power and Versatility of its ATLAS™ Antigen Identification Platform at SITC 2017

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top